Anthem, Quest ink partnership

By LabPulse.com staff writers

August 17, 2020 -- Anthem and Quest Diagnostics have announced a collaboration to improve healthcare delivery for both providers and patients.

The partnership will focus on clients in California, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, New Hampshire, New York, Ohio, Virginia, and Wisconsin. It will include tools and programs that will boost consumer engagement and offer pricing transparency for healthcare services, Quest Diagnostics said.

Quest wins approval to increase capacity for COVID-19
Quest Diagnostics has received emergency use authorization from the U.S. Food and Drug Administration to test a new laboratory technique that could bolster...
FDA grants first coronavirus clearance for sample pooling to Quest
The U.S. Food and Drug Administration has granted Quest Diagnostics the first emergency use authorization for a SARS-CoV-2 molecular diagnostic for testing...
Quest overall testing volume, revenue decline
Quest Diagnostics reported an 18% decline in overall test volume as part of a look at its preliminary financial results from the second quarter and reported...
HPV, Pap cotesting best for cervical cancer detection in Quest study
Human papillomavirus (HPV) or Pap testing alone is less likely than the combination of both methods to detect cervical cancer, according to a Quest Diagnostics...
COVID-19 testing demand delays Quest's turnaround time
Demand for COVID-19 testing continues to increase, causing further turnaround time delays for Quest Diagnostics, according to a statement released by...

Copyright © 2020 LabPulse.com

Last Updated ls 8/17/2020 3:01:41 PM